MidCap Financial Investment Corp
MFICAnalytical Summary
MidCap Financial Investment Corp faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.
24-Year Financial Trajectory
QuarterlyBullish Indicators
- No bullish signals detected.
Bearish Risks
- Debt to EquityDebt to Equity is concerning (bottom quartile)
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Mar 31, 2022 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ | Q2 FY2021 Sep 30, 2021 10-Q ↗ | Q1 FY2021 Mar 31, 2021 10-Q ↗ | Q4 FY2020 Mar 31, 2021 10-K ↗ | Q4 FY2019 Mar 31, 2020 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Growth YoY (%) | N/M | N/M | N/M |
-6.5%
Weak
↑
Weak
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
-45.7%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
-17.9%
Weak
↑
Weak
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
-52.9%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
-32.6%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
-10.3%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
-15.2%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
— |
84.0%
Excellent
↓
Excellent
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
333.3%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
557.1%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — |
-76.9%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — | — | — | — | — | — |
| Net Income Growth YoY (%) | N/M | N/M | N/M |
2.8%
Caution
↑
Caution
Improving
Year-over-year change in net income |
-19.7%
Weak
↓
Weak
Declining
Year-over-year change in net income |
19.0%
Good
↑
Good
Improving
Year-over-year change in net income |
-27.7%
Weak
↓
Weak
Declining
Year-over-year change in net income |
-10.8%
Weak
↑
Weak
Improving
Year-over-year change in net income |
-11.2%
Weak
↓
Weak
Declining
Year-over-year change in net income |
-15.4%
Weak
↓
Weak
Declining
Year-over-year change in net income |
— |
87.4%
Excellent
↓
Excellent
Declining
Year-over-year change in net income |
348.9%
Excellent
Excellent
Year-over-year change in net income |
611.0%
Excellent
Excellent
Year-over-year change in net income |
— | — | — | — | — | — | — | — | — | — |
| FCF Growth YoY (%) | N/M | N/M | — | N/M | — | N/M | — | — | — |
-79.5%
Weak
Weak
Year-over-year change in free cash flow |
— | — | N/M |
-14.8%
Weak
Weak
Year-over-year change in free cash flow |
— | — | — | — | — | — | — | — | — | — |
| EPS CAGR 3Y (%) | — | — | — |
5.1%
Fair
↓
Fair
Declining
Compound annual EPS growth over 3 years |
28.3%
Excellent
Excellent
Compound annual EPS growth over 3 years |
66.0%
Excellent
Excellent
Compound annual EPS growth over 3 years |
— | — |
-3.5%
Weak
Weak
Compound annual EPS growth over 3 years |
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Mar 31, 2022 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ | Q2 FY2021 Sep 30, 2021 10-Q ↗ | Q1 FY2021 Mar 31, 2021 10-Q ↗ | Q4 FY2020 Mar 31, 2021 10-K ↗ | Q4 FY2019 Mar 31, 2020 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF / Net Income (x) |
-10.82x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-6.30x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.50x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
6.06x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-5.03x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-4.33x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
2.28x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.38x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
0.37x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
2.36x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
0.33x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
1.52x
Excellent
→
Excellent
Stable
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
6.80x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-3.81x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
12.36x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — | — | — | — |
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Mar 31, 2022 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ | Q2 FY2021 Sep 30, 2021 10-Q ↗ | Q1 FY2021 Mar 31, 2021 10-Q ↗ | Q4 FY2020 Mar 31, 2021 10-K ↗ | Q4 FY2019 Mar 31, 2020 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Common Equity (%) (%) |
-1.6%
Weak
→
Weak
Stable
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-2.3%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-1.0%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— |
1.3%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— |
1.7%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Mar 31, 2022 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ | Q2 FY2021 Sep 30, 2021 10-Q ↗ | Q1 FY2021 Mar 31, 2021 10-Q ↗ | Q4 FY2020 Mar 31, 2021 10-K ↗ | Q4 FY2019 Mar 31, 2020 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt to Equity (x) |
1.58x
Weak
→
Weak
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.59x
Weak
Weak
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.53x
Weak
Weak
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
— | — | — |
1.25x
Caution
Caution
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt (USD) | $1.70B | $1.83B | $1.90B | $1.85B | — | $1.85B | $1.68B | — | $1.45B | $1.36B | — | $1.39B | — | $1.40B | $1.40B | — | — | — | — | — | — | — | — | — |
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Mar 31, 2022 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ | Q2 FY2021 Sep 30, 2021 10-Q ↗ | Q1 FY2021 Mar 31, 2021 10-Q ↗ | Q4 FY2020 Mar 31, 2021 10-K ↗ | Q4 FY2019 Mar 31, 2020 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LT Debt (USD) | $1.74B | $1.87B | $2.00B | $1.92B | — | $1.94B | $1.75B | — | $1.51B | $1.41B | — | $1.43B | — | $1.47B | $1.48B | — | — | — | — | — | — | — | — | — |
| Total Equity (USD) | $1.10B | $1.18B | $1.31B | — | $1.38B | — | $1.40B | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Mar 31, 2022 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ | Q2 FY2021 Sep 30, 2021 10-Q ↗ | Q1 FY2021 Mar 31, 2021 10-Q ↗ | Q4 FY2020 Mar 31, 2021 10-K ↗ | Q4 FY2019 Mar 31, 2020 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income, GAAP (USD) | $-17.50M | $-26.87M | $-12.73M | $27.45M | $18.11M | $30.33M | $24.06M | $26.72M | $22.55M | $25.49M | $33.26M | $29.96M | $25.41M | $30.13M | — | $15.99M | $5.66M | $4.24M | — | — | — | — | — | — |
| Operating Cash Flow (USD) | $189.35M | $169.39M | $6.33M | $166.27M | $-91.04M | $-131.31M | $54.77M | $-10.13M | — | $9.37M | $78.42M | — | $8.32M | $45.87M | — | $108.78M | $-21.54M | $52.40M | — | — | — | — | — | — |
Secondary lens
Benchmark Lens
Compare MFIC against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare MFIC against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for MFIC
No bullish signals detected
Debt to Equity is concerning (bottom quartile)
Percentile Rankings
How MFIC compares to all companies
Compare MFIC with peers
Stack MFIC against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced yesterday 7 years · 24 quarters